Medical Weight Loss for Woodbridge, New Jersey Residents

Woodbridge, New Jersey residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Woodbridge through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Woodbridge patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for New Jersey residents. Doctor review just $119 (medication separate).

Why Woodbridge Residents Choose New Hope Weight Loss

New Hope was designed around the way Woodbridge residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Woodbridge residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Woodbridge address.

Telehealth is what lets us care for Woodbridge, New Jersey from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout Woodbridge Township and the greater Middlesex County area. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Woodbridge patient.

Distance simply stops mattering here, since every appointment for Woodbridge residents takes place over secure video rather than in a waiting room. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Woodbridge patients. New Jersey is one of the most densely populated states in the country, and New Hope Weight Loss serves patients across it by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Woodbridge telehealth visits.

How Telehealth Works for Woodbridge

From your first quiz to your last follow-up, the process is built for busy people in Woodbridge.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Woodbridge home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Woodbridge

Can people from Woodbridge get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Woodbridge, New Jersey. Whether you are in Woodbridge Township and the greater Middlesex County area or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Woodbridge patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Woodbridge residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Woodbridge inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Woodbridge?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Woodbridge.

What areas of Woodbridge do you serve?

We serve patients from across Woodbridge by telehealth, including Woodbridge Township and the greater Middlesex County area.

Is telehealth treatment as thorough as an in-person visit for Woodbridge patients?

Yes. Woodbridge patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same health-advisor support as any patient. Everything except a physical exam is handled by secure video, and compounded medication ships to your door. Telehealth eligibility is confirmed during the consultation.

Woodbridge Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Woodbridge, New Jersey by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.